Funding Opportunity: Understanding of Cutaneous Neurofibromas

Neurofibromatosis Therapeutic Acceleration Program (NTAP) launched a new research program focused on understanding the pathogenesis of cutaneous neurofibromas.  NTAP ( is a philanthropic research entity based at Johns Hopkins University dedicated to the discovery of therapeutics for the peripheral nerve tumors that afflict people with neurofibromatosis type 1 (NF1).   This research program sets the blueprint for improving therapeutics for these tumors by encouraging research proposals that improve the Understanding of Cutaneous Neurofibromas.

The submission deadline for the ‘letter of intent’ is May 12, 2017.  Applicants will be notified by May 31, 2017 if they are invited to submit a full proposal. The request for applications announcement, includes detailed application instructions.

Please contact Dr. Sharad Verma at, or Dr. Jaishri Blakeley at  at any time with questions.
Request for Applications